...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Debt

It is a relative at 11% this time but although he is 5% this time he has done loans himself in the recent past at 10% while interest rates were near zero.

Share
New Message
Please login to post a reply